Specify a stock or a cryptocurrency in the search bar to get a summary
Intelligent Bio Solutions Inc.
INBSIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Address: 142 West 57th Street, New York, NY, United States, 10019
Analytics
WallStreet Target Price
12 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures INBS
Dividend Analytics INBS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History INBS
Stock Valuation INBS
Financials INBS
Results | 2019 | Dynamics |